| Anemia |
-
•
Increase Hb levels within 1–2 years to >11.0 g/dl and maintain Hb
-
•
Eliminate blood transfusion dependency
-
•
Reduce fatigue and dyspnea
|
| Thrombocytopenia |
-
•
Increase platelet counts during the 1st year of treatment >60 × 103 cells/mm3
-
•
Moderate thrombocytopenia: Count should increase by 1.5- to 2.0-fold by 1 year and low-normal level by 2 years
-
•
Severe thrombocytopenia: Counts should increase by 1.5- fold by 1 year and double by 2 years but normalization is not expected
-
•
Avoid splenectomy
|
| Hepatomegaly |
|
| Splenomegaly |
-
•
Reduce and maintain spleen volume to <2–8-fold normal
-
•
Reduce the spleen volume by 30% within 1 year and 60% by 2–5 years
-
•
Alleviate symptoms due to splenomegaly
|
| Bones |
-
•
Lessen or eliminate bone pain within 2 years of treatment
-
•
Prevent bone crises
-
•
Prevent osteonecrosis and joint collapse
-
•
Improve bone mineral density by 2 years of treatment
-
•
Attain normal or ideal peak skeletal mass
|
| Growth |
|